GNH USA

Europe — EMA

Levobupivacaine Fresenius Kabi

GNH USA supplies Levobupivacaine Fresenius Kabi (Levobupivacaine), a local anesthetic for epidural anesthesia, surgical and labor analgesia.

Levobupivacaine Hydrochloride

Request sourcing

1
Pack/s

What is Levobupivacaine Hydrochloride?

Levobupivacaine Hydrochloride, the active ingredient in Levobupivacaine Fresenius Kabi, is a local anesthetic (amide type) presented as a solution for epidural use. It provides regional anesthesia for surgical procedures, postoperative pain control, and labor analgesia in adult patients, offering prolonged sensory block while preserving motor function.

GNH USA supplies Levobupivacaine Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide.

What is Levobupivacaine Hydrochloride used for?

Levobupivacaine is used in the epidural pathway to provide regional anesthesia and analgesia.

Epidural anesthesia for surgery: provides surgical anesthesia and sensory block during operative procedures. Postoperative analgesia: delivers extended pain relief after surgery, reducing opioid requirement. Labor analgesia: offers effective pain control during childbirth while maintaining maternal awareness.

What are the side effects of Levobupivacaine Hydrochloride?

Adverse reactions to Levobupivacaine may range from mild to severe.

Common Side Effects: - Hypotension: reduced blood pressure due to sympathetic block. - Bradycardia: slowed heart rate. - Nausea: feeling of sickness. - Dizziness: light‑headed sensation. - Metallic taste: transient taste disturbance. - Pruritus: itching at the injection site.

Serious or Rare Side Effects: - Seizures: central nervous system excitation. - Cardiac arrest: severe arrhythmia leading to loss of circulation. - Respiratory depression: inadequate breathing. - Allergic reactions: rash, urticaria, anaphylaxis. - Prolonged motor block: extended loss of muscle function. - Methemoglobinemia: abnormal hemoglobin causing cyanosis.

What precautions apply to Levobupivacaine Hydrochloride?

When using Levobupivacaine, clinicians should observe several safety measures.

Patient assessment: evaluate cardiovascular and hepatic status before administration. Dose adjustment: reduce dose in patients with hepatic impairment. Hypersensitivity: avoid use in individuals with known allergy to amide local anesthetics. Cardiovascular monitoring: continuously monitor blood pressure and heart rate during epidural infusion. Concurrent CNS depressants: use caution when combined with opioids or benzodiazepines. Store below 25°C: keep in original packaging, protect from light and moisture.

What does Levobupivacaine Hydrochloride interact with?

Levobupivacaine may interact with other medicines, influencing its safety profile.

Major Interactions (Avoid): - Other local anesthetics: risk of cumulative systemic toxicity. - Class I antiarrhythmics (e.g., quinidine): can exacerbate cardiotoxicity. - CNS depressants (e.g., opioids, benzodiazepines): increase risk of respiratory depression.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia. - Calcium channel blockers: can potentiate hypotensive effects. - MAO inhibitors: may increase neurotoxic potential. - Non‑depolarizing muscle relaxants: may prolong neuromuscular blockade. - Diuretics: may affect plasma protein binding.

Frequently asked questions

What is Levobupivacaine Fresenius Kabi used for?+
Levobupivacaine Fresenius Kabi is a local anesthetic administered via the epidural route to provide surgical anesthesia, postoperative pain relief, and analgesia during labor. It produces a reversible sensory block, allowing patients to remain conscious while experiencing reduced pain in the targeted region.
How does Levobupivacaine work?+
Levobupivacaine works by reversibly inhibiting voltage‑gated sodium channels on neuronal membranes. This blockade prevents the initiation and propagation of action potentials, thereby halting nerve impulse transmission and producing loss of sensation in the area supplied by the affected nerves.
What is the usual dose of Levobupivacaine Fresenius Kabi?+
The dose of Levobupivacaine Fresenius Kabi is determined by the prescribing clinician based on the specific procedure, patient characteristics, and desired depth of block. Dosage calculations consider factors such as body weight, site of administration, and concurrent medications.
Is Levobupivacaine safe during pregnancy or breastfeeding?+
Safety data for Levobupivacaine in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk.
How do I order Levobupivacaine Fresenius Kabi from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.
How does Levobupivacaine compare with bupivacaine?+
Levobupivacaine is the S‑enantiomer of bupivacaine and offers a similar duration of action with a lower risk of cardiotoxicity and central nervous system toxicity. Both are amide‑type local anesthetics, but Levobupivacaine is often preferred when a safer cardiac profile is desired.
What are the storage and handling requirements for Levobupivacaine Fresenius Kabi?+
Store the product below 25 °C in its original packaging, protecting it from light and moisture. Do not freeze the solution. Ensure that the container is kept tightly sealed and that any opened vial is used within the time frame recommended by the manufacturer.
How is Levobupivacaine administered?+
Levobupivacaine is administered by an experienced clinician via the epidural route. The solution is injected into the epidural space using a sterile technique, often through a catheter, to achieve a regional block. Continuous infusion or single‑shot techniques may be employed depending on the clinical scenario.
What are the most serious risks associated with Levobupivacaine?+
Serious risks include cardiovascular toxicity such as severe hypotension, bradycardia, arrhythmias, and cardiac arrest, as well as central nervous system toxicity manifesting as seizures or respiratory depression. Prompt recognition and supportive measures are essential if these events occur.
Who should not receive Levobupivacaine?+
Levobupivacaine should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, severe hepatic impairment, or existing significant cardiac conduction abnormalities. Caution is also advised in patients receiving other sodium‑channel blocking agents or high‑dose CNS depressants.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levobupivacaine Hydrochloride
Route
Epidural Use
Manufacturer
Fresenius Kabi Nv/Sa
Origin
EU

Related products